An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer
Clinical trial NCT01660542 · COMPLETED
Trial details
- NCT number
- NCT01660542
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2015-06-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.